share_log

Options Montage: Everything at this point is likely to revolve around earnings

Options Montage: Everything at this point is likely to revolve around earnings

期權蒙太奇:此時此刻,一切都可能圍繞着收益展開
Moomoo News ·  2021/04/09 05:17  · 獨家

logo

By Eli, Rachel

作者:伊萊,雷切爾

Quiet session on Thursday with volume light across the board, institutional sweepers predominately bullish throughout the day as flow lacked quality early on but finished ok. 

週四交易日平靜,全線成交量清淡,機構清道夫全天以看漲為主,因為早些時候資金流動缺乏質量,但收盤時還可以。

The top bet list consisted of names like $Square, INC.(SQ.US)$ which also saw a huge chunk of its buying in short-term weeklies. 

最受歡迎的賭注名單由如下名字組成$Square,Inc.(SQ.US)$其中很大一部分買入來自短期週刊。

On the sentiment front 

在情緒方面

Short-term sentiment remains on the warm side as there haven't any signs of selling or profit taking yet.

短期人氣仍然偏暖,因為目前還沒有任何拋售或獲利回吐的跡象。

20210409000077468f43d0dad3a.jpg

Gamma Exposure vs SPY source: sentimentrader

伽馬暴露VS標普500ETF來源:SentimenTrader

Gamma exposure continues to spike which will add to the stickiness in price action and make it difficult to see any sort of downside momentum. 

伽馬暴露量繼續飆升,這將增加價格走勢的粘性,使人們很難看到任何形式的下跌勢頭。

Dip buyers are in full effect for now, maybe Friday's expiration will help loosen things up a bit but being just weekly expiration, it likely won't make much of a dent. 

DIP買家目前完全有效,也許週五的到期將有助於放鬆一些,但由於只有一週的到期,它可能不會有太大影響。

To sum up

要而論之

Elevated gamma readings, the start of earnings season, strong economic numbers daily really set up well for a drift higher in the indices. Outside of some unforeseen news to serve as a catalyst, the most we can likely hope for is a quick rinse over the extremely short-term, at least up until the start of earnings season when the banks get things going there. Quality and big tech continue to be the spot of interest out there, and that doesn't just mean FAANG either. Keep an eye on momentum names and some of the other quality growth names as players look for exposure into earnings. Everything at this point is likely to revolve around earnings, so if we do get some sort of dip, it will be buyable.

伽馬讀數的上升、財報季的開始、每天強勁的經濟數據,確實為指數的漂移奠定了良好的基礎。除了一些不可預見的消息起到催化劑作用外,我們最多可能希望的是在極短的時間內迅速洗牌,至少在財報季開始之前是這樣,屆時銀行會有所進展。質量和大型科技仍然是人們感興趣的地方,這也不僅僅意味着FAANG。在玩家尋求收益敞口之際,密切關注動量名稱和其他一些高質量增長名稱。在這一點上,一切都可能圍繞着收益,所以如果我們真的出現某種程度的下跌,它將是可以買入的。

With all the factors mentioned, including earnings, they likely won't let things get too far away to the downside over the extremely short-term, at least until some names start reporting numbers.

考慮到上述所有因素,包括盈利,他們可能不會讓情況在極短的時間內變得太糟糕,至少在一些公司開始公佈業績之前是這樣。

Notable bettings toward broader market indices ETF on 4/8

4/8對大盤指數ETF的值得注意的押注

Thursday's option volume of 31.1m contracts was 14% below recent average levels, with calls leading puts 7 to 4.Index and Single stock products saw relatively heavy volume, while ETF flow was moderate. 

週四的期權成交量為3,110萬份,較近期平均水平低14%,看跌期權佔比為7:4。指數和單一股票產品的成交量相對較大,而ETF的成交量不大。

Individuals breakdown by sectors (4/8 notable bets)

按行業細分的個人(4/8值得注意的賭注)

Today's mostactive sectors included Telecommunications, Utilities and Technology, while Consumer Cyclicals and Industrials were relatively light.Of the 3909 stocks with listed options, 2468 (63%) closed higher, and 1342 (34)% lower. Among the 500 most liquid single stocks, 30day implied volatility was higher for 143 and lower for 313. Unusual total option volume was observed in $CLOVER HEALTH INVESTMENTS CORP(CLOV.US)$, $Peloton Interactive Inc(PTON.US)$, $Roku Inc(ROKU.US)$$Blink Charging Co(BLNK.US)$ and $Star Peak Energy Transition Corp(STPK.US)$.

今日最活躍的板塊包括電信、公用事業和科技,而消費品和工業類股相對清淡。在3909只有期權上市的股票中,2468只(63%)收盤走高,1342只(34%)下跌。在流動性最強的500只單一股票中,30日隱含波動率較高的有143只,較低的有313只。觀察到異常的期權總成交量$三葉草健康投資公司(CLOV.US)$, $Peloton Interactive Inc.(PTON.US)$, $Roku Inc.(ROKU.US)$, $Blink Charging Co(BLNK.US)$$Star Peak Energy Transfer Corp(STPK.US)$.

Tech

高科技

Industrial

工業

Consumer Cyclical

消費週期

Financial

金融

Communication Services

通信服務

Healthcare

醫療保健

Energy

能量

Real Estate

房地產

Basic materials

基礎材料

Consumer Defensive

消費者防禦性

Utilities

公用事業

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論